Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology |
| |
| Authors: | Godinho Kevin S Keane Sue G Nanjiani Ian A Benchaoui Hafid A Sunderland Simon J Jones M Anne Weatherley Andrew J Gootz Thomas D Rowan Tim G |
| |
| Institution: | Veterinary Medicine Research and Development, Pfizer Ltd, Sandwich, Kent, UK. |
| |
| Abstract: | The in vitro activity of tulathromycin was evaluated against common bovine and porcine respiratory pathogens collected from outbreaks of clinical disease across eight European countries from 1998 to 2001. Minimum inhibitory concentrations (MICs) for one isolate of each bacterial species from each outbreak were determined using a broth microdilution technique. The lowest concentrations inhibiting the growth of 90% of isolates (MIC90) for tulathromycin were 2 microg/ml for Mannheimia (Pasteurella) haemolytica, 1 microg/ml for Pasteurella multocida (bovine), and 2 microg/ml for Pasteurella multocida (porcine) and ranged from 0.5 to 4 microg/ml for Histophilus somni (Haemophilus somnus) and from 4 to 16 microg/ml for Actinobacillus pleuropneumoniae. Isolates were retested in the presence of serum. The activity of tulathromycin against fastidious organisms was affected by culture conditions, and MICs were reduced in the presence of serum. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
